Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Hovione Will Buy Pfizer's Ireland Plant
by Patricia L. Short
December 15, 2008
| A version of this story appeared in
Volume 86, Issue 50
Portuguese fine chemicals producer Hovione will acquire Pfizer's pharmaceutical chemical plant in Loughbeg, County Cork, Ireland, for an undisclosed sum. The site, which has 427 m3 of capacity and makes intermediates for Lipitor, will continue to serve Pfizer. Hovione says it will also begin transferring products from Portugal and validating processes for new customer products that appear slated for drug approval. With the acquisition, Hovione's production capacity will be divided roughly evenly among plants in Ireland, Portugal, and China.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter